AzTrials
AzTrials

Pressure SoreEDUCESCARRESNCT05547295

Evaluation of the Impact of a Digital Tool MEDIASCREEN of Preventive Information for Patients on the Knowledge of the Risk of Pressure Sores Acquired During a Hospitalization

A study testing Numeric prevention and Paper prevention in people with Pressure Sore, run by Pôle Saint Hélier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study focuses on the impact of a digital MEDIASCREEN tool on the knowledge, technical know-how and behavioural skills in terms of pressure sores of patients. In addition, the cognitive impact of this type of tool will also be studied in our study population (self-esteem and feeling of personal effectiveness). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pressure Sore
What is being tested?
Numeric prevention and Paper prevention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteFrance
Study dates
27 Oct 2022to 16 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient in complete hospitalization in Physical Medicine and Rehabilitation
  • Patient affiliated to a social security system
  • Patient presenting a low to high risk of pressure ulcer inferior or equal to or equal to 16 on the Norton scale
  • Patient having signed his consent

Who cannot join

  • Difficulty understanding and is unable to give free and informed consent
  • Pregnant women
  • Person deprived of liberty by a judicial or administrative administrative decision
  • Major under legal protection by a judicial or administrative decision.
  • Person in an emergency situation unable to give their informed consent

Trial locations and contacts

1 site in 1 country.

France1 site
  • Pôle Saint-Hélier

    Rennes, Brittany Region, 35000

Other trials in France

About this study

Official title: Evaluation of the Impact of a Digital Tool MEDIASCREEN of Preventive Information for Patients on the Knowledge of the Risk of Pressure Sores Acquired During a Hospitalization, a Randomized Controlled Pilot Interventional Study in Single Blind

The study focuses on the impact of a digital MEDIASCREEN tool on the knowledge, technical know-how and behavioural skills in terms of pressure sores of patients. In addition, the cognitive impact of this type of tool will also be studied in our study population (self-esteem and feeling of personal effectiveness). The objective is to compare the impact of a digital MEDIASCREEN information tool with information tool compared to the usual paper-based prevention materials on knowledge of the risk of hospital-acquired pressure sores.

Conditions
Pressure Sore
Being tested
Numeric prevention, Paper prevention
Medical subject headings
Pressure Ulcer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Numeric preventionOther

    Numeric information for prevention of pressure sores thgrough digital tool MEDIASCREEN

  • Paper preventionOther

    Information for prevention of pressure sores in classic way with paper

Study groups in NCT05547295
Study groupRoleWhat they receive
Paper InformationOtherPatient will have classic paper information for prevention of pressure sores
Receives: Other: Paper prevention
Numeric information from MEDIASCREENExperimentalPatient will have information for prevention of pressure sores throught the digital tool MEDIASCREEN
Receives: Other: Numeric prevention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluate the change on the knowledge of the risk of hospital-acquired pressure sores with a digital MEDIASCREEN information tool in comparison to the usual paper-based prevention materials

    The comparison will be done with Skin-Management Needs Assessment Checklist score (SMNac). Minimum value =0, Maximum value = 100; higher score better outcome.

    Measured: Change from baseline knowledge at 1 month

Secondary outcomes (9)
  1. Evaluate patient satisfaction with the information delivered by the MEDIASCREEN digital tool

    Measured by Visual Analogic scale from 0 to 100. Zero is represented : "Not at all satisfied" and 100 : "Completely satisfied".

    Higher scores better outcome.

    Measured: At 1 month

  2. Assess the cognitive impact of the prevention information delivered by MEDIASCREEN tool, on self-esteem.

    Measured of self-esteem with Rosenberg scale. Score range : 10-40. High scores indicate high self esteem.

    Measured: At the beginning and at 1 month

  3. Assess the cognitive impact of the prevention information delivered by MEDIASCREEN tool, on sense of self-efficacy.

    Measured of self-efficacy with scale to evaluate the feeling of personal effectiveness (MSES) Score range: 16-80. High scores indicate high feeling of personal effectiveness.

    Measured: At the beginning and at 1 month

  4. Evaluate the psychological impact of information delivered from the tools

    Measured by Visual Analogic scale from 0 to 100. Zero is represented : "No knowledge" and 100 : "Perfectly mastered subject".

    Higher scores better outcome.

    Measured: At 1 month

  5. Evaluate the occurrence of pressure sores during hospitalization

    Count of the apparition number of pressure sores.

    Measured: At the beginning and at 1 month

  6. Evaluate the acquisition of knowledge by patients

    Evaluate with questionnaire of knowledge, compose by 5 questions on three points each. The overall questionnaire will be on 15 points.

    Higher scores better outcome.

    Measured: At 1 month

  7. Evaluate the user experience when using the digital tool MEDIASCREEN.

    Measured by Questionnaire Attrakdiff for the user experience. The AttrakDiff questionnaire contains 28 question with 7 Likert-type scale from -3 to 3.

    Measured: At 1 month

  8. Evaluate the observance when using the digital tool MEDIASCREEN.

    Measured by the connexion data : number of connexion, duration of connexion, percentage of completion.

    Measured: At 1 month

  9. Evaluate the acceptability of the digital information tool MEDIASCREEN digital information tool or the paper information brochure.

    The acceptability will be assessed using a 13-item questionnaire based on the Unified Theory of Acceptance and Use of Technology (UTAUT) model. Each question is based on a Likert-type 5 point scale ranging from : 1=In total disagreement, 2= Somewhat disagree, 3= Neither agree nor disagree, 4= Somewhat agree, 5=In total agreement.

    Measured: At the beggining and at 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2022
  2. Study start27 Oct 2022
  3. Primary completion16 Jan 2025
  4. Study completion16 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Investigator
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05547295
Sponsor's protocol ID
2022-A00520-43
Acronym
EDUCESCARRES
Status last verified
Jul 2025
First submitted
7 Jul 2022
Last updated
30 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Numeric prevention and Paper prevention in people with Pressure Sore, run by Pôle Saint Hélier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluate the change on the knowledge of the risk of hospital-acquired pressure sores with a digital MEDIASCREEN information tool in comparison to the usual paper-based prevention materials (time frame: Change from baseline knowledge at 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in